Caption Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Caption Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$8.19M	–	2048
2025 Q4	$8.19M	Buy	100,000 +85,400	+585%	+$6.38M	0.06%	380
2025 Q3	$868K	Buy	+14,600	New	+$719K	0.01%	1151
2024 Q4	–	Sell	-300,100	Closed	-$9.87M	–	1816
2024 Q3	$9.87M	Buy	+300,100	New	+$8.43M	0.16%	157

Other funds holding TARS

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caption Management's TARS Position: Q1 2026 in Review

Caption Management opened a new position in Tarsus Pharmaceuticals (TARS) in Q1 2026: 36,448 shares worth $2.56M. The stake represents 0.01% of the portfolio and ranks #751 among its holdings.

253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

Caption Management held 36,448 shares of Tarsus Pharmaceuticals worth $2.56M as of Q1 2026.
Tarsus Pharmaceuticals was a new Caption Management position in Q1 2026.
Tarsus Pharmaceuticals made up 0.01% of Caption Management's portfolio in Q1 2026, its #751 holding.
253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.